Demand for breast implants procedures estimated to propel the growth of the breast implants market

Breast Implants Market by Implant Type (Silicone Implant and Saline Implant), Application (Breast Reconstruction and Breast Augmentation), End User (Hospitals and Cosmetology Clinics) – Global Outlook & Forecast 2021-2031

According to the deep-dive market assessment study conducted by Growth+ Reports, the global breast implants market was pegged at ~US$ 2.76 billion in 2020. The market is expected to witness a CAGR of ~10.7% from 2021 to 2031. 

The rising prevalence of breast cancer, growing number of breast implant procedures, technological advancements, and increasing demand for cosmetic surgical procedures are some of the pivotal factors propelling the growth of the breast implants market. However, the high cost of implant procedures and complications associated with the use of implants are likely to restrain the market growth to a certain extent.

Government bodies and various organizations across the globe are taking several initiatives to fast-track the development of breast implants by providing the necessary funding, grants, permissions, clearances, and approvals. For instance, in February 2018, the health department of the South Indian state Tamil Nadu launched free cosmetic surgery clinic at the Government Stanley Medical College and Hospital which will provide free breast implants or breast reconstruction surgeries to poor people. Government and regulatory bodies are also working towards awareness about the complications of breast implants. For instance, in Oct 2021, the U.S. Food and Drug Administration took several new actions to strengthen breast implant risk communication and to ensure that patients considering breast implants are provided with adequate risk information so that they can make fully informed decisions.

Breast cancer arises in the lining cells (epithelium) of the ducts (85%) or lobules (15%) in the glandular tissue of the breast. Breast cancer is the second most common form of cancer among women in the United States. It is a leading cause of cancer death in less developed countries. In 2020, around 2.3 million women were diagnosed with breast cancer and about 685,000 women died due to breast cancer globally. The death rate for breast cancer is higher than those for any other cancer in U.S. women. Mastectomy is a surgery to remove all breast tissue from a breast and is commonly adopted as a way to treat or prevent the spread of breast cancer. After mastectomy, breast implantation is the most common option used for breast reconstruction. In 2019, around 107,000 breast reconstruction procedures were performed in the U.S., of which 80% of procedures were performed using implants. Hence, the rising incidence of breast cancer and increasing adoption of implantation after mastectomy, are expected to boost the growth of the market.

Breast augmentation/augmentation mammoplasty is a surgical procedure that aims to increase the size, change the shape, and alter the texture of the breasts of a woman. Breast augmentation is a type of cosmetic surgery performed mainly for esthetic purposes. According to 2017 data published by the American Society of Plastic Surgeons (ASPS), breast augmentation was the most frequently performed cosmetic surgical procedure nationwide and constituted around 17% of the total plastic surgeries performed. An increasing number of augmentation surgeries is expected to propel the growth of the market.

However, complications related to breast implants are expected to restrain the market growth to a certain extent. Common complications associated with breast implants include infection, chronic breast pain, rupturing or leaking of the implant, necrosis, and breast or nipple numbness. Furthermore, among the patients who had undergone reconstruction surgery, around 45% of patients with silicone gel implants and around 20% with saline implants underwent at least one additional operation within 3 years. Whereas, around 25% of patients with silicone implants and 8% of patients with saline implants removed their implants. Therefore, complications associated with implants and an increase in the overall cost due to these complications are expected to limit the growth of the market.

The Asia Pacific region is projected to be the fastest-growing breast implants market. The high growth of the region can mainly be attributed to the developing healthcare infrastructure, rising disposable income, changing lifestyles, and rising prevalence of breast cancer. Countries such as India, China, and Japan in the APAC region, are projected to offer significant growth opportunities owing to the presence of a large population and the rising medical tourism in the region.

Some of the prominent players operating in the breast implants market are AbbVie, Polytech Health & Aesthetics GmbH, Johnson & Johnson Services, Inc., Sebbin, Sientra, Inc., GC Aesthetics, Silimed, Establishment Labs S.A., Ideal Implant Incorporated, and Laboratoires Arion, among others.

awards awards key differentiators

Reach Us

enquire@growthplusreports.com

Web –  www.growthplusreports.com